These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 426503)

  • 1. Pharmacokinetics of amoxicillin: Dosage nomogram for patients with impaired renal function.
    Humbert G; Spyker DA; Fillastre JP; Leroy A
    Antimicrob Agents Chemother; 1979 Jan; 15(1):28-33. PubMed ID: 426503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of amoxicillin in subjects with normal and impaired renal function.
    Arancibia A; Drouguett MT; Fuentes G; González G; González C; Thambo S; Palombo G
    Int J Clin Pharmacol Ther Toxicol; 1982 Oct; 20(10):447-53. PubMed ID: 7141752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of parenteral amoxycillin, biliary excretion and effect of renal failure.
    Chelvan P; Hamilton-Miller JM; Brumfitt W
    J Antimicrob Chemother; 1979 Mar; 5(2):232-3. PubMed ID: 429253
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
    Blum RA; Kohli RK; Harrison NJ; Schentag JJ
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of intravenous amoxicillin in patients on long-term dialysis.
    Francke EL; Appel GB; Neu HC
    Clin Pharmacol Ther; 1979 Jul; 26(1):31-5. PubMed ID: 445959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration.
    Spyker DA; Rugloski RJ; Vann RL; O'Brien WM
    Antimicrob Agents Chemother; 1977 Jan; 11(1):132-41. PubMed ID: 836010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
    Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
    Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function.
    Spyker DA; Thomas BL; Sande MA; Bolton WK
    Antimicrob Agents Chemother; 1978 Aug; 14(2):172-7. PubMed ID: 697345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K; Ozawa Y
    Antimicrob Agents Chemother; 1984 Nov; 26(5):647-51. PubMed ID: 6097172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cefmenoxime in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K
    Antimicrob Agents Chemother; 1986 Dec; 30(6):901-5. PubMed ID: 3468882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical pharmacology of amoxicillin and ampicillin administered orally.
    Gordon C; Regamey C; Kirby WM
    Antimicrob Agents Chemother; 1972 Jun; 1(6):504-7. PubMed ID: 4680813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human intravenous and intramuscular pharmacokinetics of amoxicillin.
    Mastrandrea V; Ripa S; La Rosa F; Tarsi R
    Int J Clin Pharmacol Res; 1984; 4(3):209-12. PubMed ID: 6490239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.
    Leroy A; Humbert G; Godin M; Fillastre JP
    Antimicrob Agents Chemother; 1980 Mar; 17(3):344-9. PubMed ID: 7425600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefaclor in renal failure: effects of multiple doses and hemodialysis.
    Spyker DA; Gober LL; Scheld WM; Sande MA; Bolton WK
    Antimicrob Agents Chemother; 1982 Feb; 21(2):278-81. PubMed ID: 7073265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous amoxicillin in pediatric patients.
    Rudoy RC; Goto N; Pettit D; Uemura H
    Antimicrob Agents Chemother; 1979 Apr; 15(4):628-9. PubMed ID: 464594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amoxycillin: pharmacokinetic studies in normal subjects, patients with pernicious anaemia and those with renal failure.
    Lawson DH; Henderson AK; McGeachy RR
    Postgrad Med J; 1974 Aug; 50(586):500-3. PubMed ID: 4618910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin.
    Horber FF; Frey FJ; Descoeudres C; Murray AT; Reubi FC
    Antimicrob Agents Chemother; 1986 Apr; 29(4):614-9. PubMed ID: 3707111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of sisomicin: dosage schedules in renal-impaired patients.
    Pechère JC; Pechère MM; Dugal R
    Antimicrob Agents Chemother; 1976 May; 9(5):761-5. PubMed ID: 986124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Choice of amoxycilin dosage in impaired renal function (author's transl)].
    Dzúriková V; Simkovicová M; Fedelesová V; Dzúrik R
    Bratisl Lek Listy; 1978 Apr; 69(4):468-73. PubMed ID: 638809
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of hemodialysis on the pharmacokinetics of amoxicillin/clavulanic acid combination.
    Slaughter RL; Kohli R; Brass C
    Ther Drug Monit; 1984; 6(4):424-7. PubMed ID: 6393464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.